Clearbridge Health Past Earnings Performance
Past criteria checks 0/6
Clearbridge Health's earnings have been declining at an average annual rate of -13.6%, while the Healthcare industry saw earnings growing at 15.1% annually. Revenues have been declining at an average rate of 6.4% per year.
Key information
-13.6%
Earnings growth rate
-4.7%
EPS growth rate
| Healthcare Industry Growth | 9.7% |
| Revenue growth rate | -6.4% |
| Return on equity | -244.5% |
| Net Margin | -280.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Clearbridge Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 11 | -32 | 6 | 0 |
| 30 Sep 23 | 12 | -19 | 6 | 0 |
| 30 Jun 23 | 13 | -6 | 6 | 0 |
| 31 Mar 23 | 15 | -9 | 6 | 0 |
| 31 Dec 22 | 16 | -12 | 6 | 0 |
| 30 Jun 22 | 4 | -17 | 5 | 0 |
| 31 Mar 22 | 8 | -16 | 6 | 0 |
| 31 Dec 21 | 11 | -16 | 7 | 0 |
| 30 Sep 21 | 33 | -18 | 14 | 0 |
| 30 Jun 21 | 31 | -11 | 8 | 0 |
| 31 Mar 21 | 37 | -4 | 10 | 0 |
| 31 Dec 20 | 36 | 1 | 8 | 0 |
| 30 Sep 20 | 37 | 3 | 8 | 0 |
| 30 Jun 20 | 36 | -6 | 9 | 0 |
| 31 Mar 20 | 27 | -10 | 8 | 0 |
| 31 Dec 19 | 22 | -11 | 8 | 0 |
| 30 Sep 19 | 15 | -10 | 9 | 0 |
| 30 Jun 19 | 11 | -6 | 8 | 0 |
| 31 Mar 19 | 8 | -17 | 8 | 0 |
| 31 Dec 18 | 6 | -18 | 7 | 0 |
| 30 Sep 18 | 4 | -21 | 5 | 0 |
| 30 Jun 18 | 2 | -21 | 5 | 0 |
| 31 Mar 18 | 1 | -9 | 4 | 0 |
| 31 Dec 17 | 0 | -7 | 3 | 0 |
| 30 Sep 17 | 0 | -3 | 3 | 0 |
| 30 Jun 17 | 0 | 1 | 4 | 0 |
| 31 Mar 17 | 0 | -1 | 4 | 0 |
| 31 Dec 16 | 0 | -2 | 4 | 0 |
| 31 Dec 15 | 0 | 5 | 2 | 0 |
| 31 Dec 14 | 0 | 5 | 2 | 0 |
Quality Earnings: 1H3 is currently unprofitable.
Growing Profit Margin: 1H3 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1H3 is unprofitable, and losses have increased over the past 5 years at a rate of 13.6% per year.
Accelerating Growth: Unable to compare 1H3's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 1H3 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-2%).
Return on Equity
High ROE: 1H3 has a negative Return on Equity (-244.52%), as it is currently unprofitable.